Detection of t(8;21) by reverse transcriptase polymerase chain reaction in patients in remission of acute myeloid leukaemia type M2 after chemotherapy or bone marrow transplantation
- 1 December 1994
- journal article
- editorial
- Published by Elsevier in Leukemia Research
- Vol. 18 (12) , 891-895
- https://doi.org/10.1016/0145-2126(94)90100-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemiaBritish Journal of Haematology, 1994
- Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNABlood, 1993
- Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantationBlood, 1993
- Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remissionBlood, 1993
- An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocationBlood, 1993
- Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemiaBlood, 1993
- Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runtBlood, 1992
- Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extractionAnalytical Biochemistry, 1987